Table IV.
Association between the NOS3 polymorphism [rs1800779(A/G)] and clinical-demographic characteristics of both groups.
| Genotype | Age (year) | Sex (m/f) | FBS (mg/dl) | TC (mg/dl) | TG (mg/dl) | HDL-C (mg/dl) | LDL-C (mg/dl) | BMI (kg/m2) |
|---|---|---|---|---|---|---|---|---|
| T2D | ||||||||
| AA | 54.92±10.18 | 39/103 | 211.14±105.27 | 188.12±47.44 | 163.36±73.87 | 54.09±20.75 | 104.11±39.88 | 27.31±4.50 |
| AG+GG | 54.37±10.25 | 38/70 | 187.01±92.87 | 185.54±49.24 | 167.69±89.90 | 51.40±17.43 | 100.58±35.91 | 27.98±6.53 |
| P-value | 0.961 | 0.214 | 0.237 | 0.790 | 0.086 | 0.168 | 0.261 | 0.434 |
| Control | ||||||||
| AA | 48.80±10.27 | 33/74 | 101.11±34.34 | 178.79±36.63 | 141.20±72.89 | 52.30±12.93 | 101.63±25.85 | 21.39±2.41 |
| AG+GG | 50.20±9.78 | 39/104 | 101.64±26.63 | 179.82±36.14 | 144.57±87.95 | 54.31±14.04 | 101.40±31.09 | 21.65±2.57 |
| P-value | 0.642 | 0.574 | 0.403 | 0.543 | 0.783 | 0.686 | 0.183 | 0.419 |
M, male; F, female; FBS, fasting blood sugar; TC, total cholesterol; TG, triglyceride; HDL-C, high density lipoprotein-cholesterol; LDL-C, low density lipoprotein-cholesterol; BMI, body mass index; T2D, type 2 diabetes.